CANCER AND LEUKEMIA GROUP B
CANCER AND LEUKEMIA GROUP B
批准号:
3557184
负责人:
BRIAN LEYLAND-JONES
金额:
$6.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-07-15 至 1993-03-31
关键词:
Abelson leukemia virus Hodgkin's disease T lymphocyte acute leukemia antigen receptors autologous transplantation behavior test bladder neoplasm bone marrow transplantation breast neoplasms cancer information system cell growth regulation cell mediated lymphocytolysis test colony stimulating factor combination cancer therapy cooperative study cyclosporines glutamates glycosyltransferase health behavior hematopoietic stem cells histocompatibility human subject human therapy evaluation interleukin 2 lung neoplasms lymphoma messenger RNA methotrexate molecular cloning molecular oncology monoclonal antibody neoplasm /cancer chemotherapy neoplasm /cancer immunology neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy neoplasm /cancer remission /regression neoplasm /cancer surgery neoplastic cell nucleic acid probes virus RNA
中文摘要
麦吉尔大学医院过去曾参加过CALGB
25年 在过去的五年里,NCI的资助使
建立有效的数据收集系统,
五家参与医院由麦吉尔大学
癌症中心 与此同时,
麦吉尔在肿瘤疾病的临床导向研究。 作为
工作组活动从被动地为议定书作出贡献
参与数据评价和方案制定的案例
1986年,病例应计发生了短暂恶化。
这一点已得到承认和纠正。 应计额现已达到目标
按年率计算为140美元,部分原因是
足够的数据收集工作人员为伊丽莎白女王和圣。
玛丽的医院在过去的几个月里。 麦吉尔参与
在CALGB的学术和行政活动中,
在过去5年中,
一些核心委员会和大多数行政委员会。
我们计划扩大我们在淋巴瘤领域的参与,
免疫学 麦吉尔大学的主要免疫学研究项目包括
关于CALB的兴趣 输入计划骨髓
移植计划将是重要的,因为麦吉尔是其中之一,
在加拿大领先的骨髓移植中心,并有一个积极的
在过去的七年里,在自体和
异基因骨髓移植 许多研究项目
麦吉尔大学正在进行的肿瘤学领域的研究为以下方面提供了坚实的基础:
增加对CALGB研究的科学投入。 这些都是详细的
在机构简介中。
英文摘要
McGill University hospitals have participated in CALGB for the past
25 years. NCI funding for the past five years has permitted the
establishment of an effective system of data collection throughout
the five participating hospitals which is directed by the McGill
Cancer Centre. This has coincided with increased activity at
McGill in clinically directed research in neoplastic diseases. As
the Group's activity shifted from passive contribution of protocol
cases to participation in data evaluation and protocol generation
some transient deterioration in case accrual occurred in 1986.
This has been recognized and corrected. Accrual is now on target
at an annualized rate of 140, due in part to the provision of
adequate data collecting staff for the Queen Elizabeth and St.
Mary's Hospitals during the past few months. McGill participating
in the academic and administrative activities of CALGB has
increased markedly over the past 5 years with representation on
several core and on most of the administrative committees.
We plan to extend our participation in the field of lymphoma and
immunology. McGill has major immunology research projects in areas
related to CALGB interest. Input into the planned bone marrow
transplantation program will be significant as McGill is one of the
leading marrow transplant centers in Canada and has had an active
program during the past seven years in both autologous and
allogeneic marrow transplantation. The many research projects
under way at McGill in the oncology field provide a sound basis for
increased scientific input into CALGB studies. These are detailed
in the Institutional Profile.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards identification of prognostic gene sets in breast cancer: The E2197 Trial
-
批准号:8111749
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2010
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
Towards identification of prognostic gene sets in breast cancer: The E2197 Trial
-
批准号:7878367
-
项目类别:
-
资助金额:$21.11万
-
财政年份:2010
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS - PROTOCOL REVIEW MONITORING SYSTEM
-
批准号:7944911
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DATA SAFETY MONITORING PLAN
-
批准号:7944930
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
PROGRAM PLANNING & EVALUATION
-
批准号:7944862
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DEVELOPMENTAL FUNDS
-
批准号:7944866
-
项目类别:
-
资助金额:$13.41万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS- PROTOCOL SPECIFIC
-
批准号:7944927
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
Prognostic and predictive gene sets in HER2-positive breast cancer:The HERA Trial
-
批准号:7643722
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
SENIOR LEADERSHIP
-
批准号:7944855
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
SENIOR LEADERSHIP
-
批准号:8089515
-
项目类别:
-
资助金额:$18.36万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS- PROTOCOL SPECIFIC
-
批准号:8089529
-
项目类别:
-
资助金额:$1.15万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DEVELOPMENTAL FUNDS
-
批准号:8089518
-
项目类别:
-
资助金额:$15.57万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
PROGRAM PLANNING & EVALUATION
-
批准号:8089517
-
项目类别:
-
资助金额:$5.92万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS - PROTOCOL REVIEW MONITORING SYSTEM
-
批准号:8089528
-
项目类别:
-
资助金额:$8.71万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DATA SAFETY MONITORING PLAN
-
批准号:8089530
-
项目类别:
-
资助金额:$1.61万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
海外基金